​

Alkermes (ALKS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

ALKS Stock Forecast

Alkermes (ALKS) stock forecast, based on 29 Wall Street analysts, predicts a 12-month average price target of $54.33, with a high of $65.00 and a low of $43.00. This represents a 2.57% increase from the last price of $52.97.

$20 $29 $38 $47 $56 $65 High: $65 Avg: $54.33 Low: $43 Last Closed Price: $52.97

ALKS Stock Rating

Alkermes stock's rating consensus is Buy, based on 29 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (55.17%), 10 Hold (34.48%), 3 Sell (10.34%), and 0 Strong Sell (0.00%).

Buy
Total 29 0 3 10 16 Strong Sell Sell Hold Buy Strong Buy

ALKS Price Target Upside V Benchmarks

TypeNameUpside
StockAlkermes2.57%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts2515
Avg Price Target$64.00$57.60$49.73
Last Closing Price$52.97$52.97$52.97
Upside/Downside20.82%8.74%-6.12%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jul, 263112-117
Jun, 263113--17
May, 263123--18
Apr, 263123--18
Mar, 263123--18
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Jul 20, 2026Paul MatteisStifel Nicolaus$63.00$52.7219.50%18.94%
Jul 02, 2026Vamil DivanMizuho Securities$65.00$51.7225.68%22.71%
Jun 18, 2026Ami FadiaNeedham$54.00$44.5121.32%1.94%
Jun 09, 2026Leonid TimashevRBC Capital$56.00$44.0827.04%5.72%
May 06, 2026Needham$50.00$35.6240.37%-5.61%
Feb 26, 2026Douglas TsaoH.C. Wainwright$43.00$31.0438.53%-18.82%
Feb 23, 2026Wolfe Research$45.00$32.1939.79%-15.05%
Oct 28, 2025Akash TewariJefferies$56.00$30.7582.11%5.72%
Oct 27, 2025Mizuho Securities$45.00$29.7651.21%-15.05%
Oct 23, 2025David AmsellemPiper Sandler$45.00$31.0944.74%-15.05%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jun 29, 2026Wells FargoOverweightOverweighthold
Jun 22, 2026Cowen & Co.BuyBuyhold
Jun 18, 2026NeedhamBuyBuyhold
Jun 18, 2026H.C. WainwrightNeutralNeutralhold
Jun 09, 2026RBC CapitalOutperformOutperformhold
May 06, 2026NeedhamBuyBuyhold
May 06, 2026UBSBuyBuyhold
Mar 24, 2026Piper SandlerOverweightOverweighthold
Feb 26, 2026H.C. WainwrightNeutralNeutralhold
Feb 23, 2026Wolfe ResearchOutperforminitialise

Financial Forecast

EPS Forecast

Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.30$-0.97$2.14$2.22$1.47---
Avg Forecast$0.58$0.23$1.60$2.62$1.74$1.97$1.68$1.80
High Forecast$0.61$0.24$1.79$2.80$1.98$2.76$2.60$1.88
Low Forecast$0.57$0.22$1.51$2.39$1.23$0.34$0.49$1.68
Surprise %-151.72%-521.74%33.75%-15.27%-15.52%---

Revenue Forecast

$1B $1B $1B $1B $2B $2B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$1.17B$1.11B$1.66B$1.56B$1.48B---
Avg Forecast$1.16B$1.10B$1.65B$1.51B$1.41B$1.46B$1.43B$1.47B
High Forecast$1.20B$1.13B$1.67B$1.52B$1.46B$1.47B$1.43B$1.52B
Low Forecast$1.13B$1.05B$1.62B$1.48B$1.35B$1.45B$1.42B$1.39B
Surprise %1.35%1.37%0.85%3.27%4.94%---

Net Income Forecast

$-1B $-600M $-200M $200M $600M $1B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-48.17M$-158.27M$355.76M$367.07M$241.66M---
Avg Forecast$-151.10M$-447.50M$519.16M$441.17M$272.37M$211.64M$210.29M$304.67M
High Forecast$-111.66M$-355.81M$625.33M$476.00M$336.78M$469.15M$441.92M$319.43M
Low Forecast$-190.54M$-539.19M$412.99M$406.34M$207.96M$57.12M$83.33M$285.39M
Surprise %-68.12%-64.63%-31.47%-16.80%-11.27%---

ALKS Forecast FAQ

Is Alkermes stock a buy?

Alkermes stock has a consensus rating of Buy, based on 29 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 10 Hold, 3 Sell, and 0 Strong Sell, reflecting a consensus that Alkermes is a favorable investment for most analysts.

What is Alkermes's price target?

Alkermes's price target, set by 29 Wall Street analysts, averages $54.33 over the next 12 months. The price target range spans from $43 at the low end to $65 at the high end, suggesting a potential 2.57% change from the previous closing price of $52.97.

How does Alkermes stock forecast compare to its benchmarks?

Alkermes's stock forecast shows a 2.57% upside, underperforming the average forecast for the healthcare stocks sector (15.45%) and underperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Alkermes over the past three months?

  • July 2026: 17.65% Strong Buy, 64.71% Buy, 11.76% Hold, 0% Sell, 5.88% Strong Sell.
  • June 2026: 17.65% Strong Buy, 64.71% Buy, 17.65% Hold, 0% Sell, 0% Strong Sell.
  • May 2026: 16.67% Strong Buy, 66.67% Buy, 16.67% Hold, 0% Sell, 0% Strong Sell.

What is Alkermes’s EPS forecast?

Alkermes's average annual EPS forecast for its fiscal year ending in December 2026 is $1.97, marking a 34.01% increase from the reported $1.47 in 2025. Estimates for the following years are $1.68 in 2027, and $1.8 in 2028.

What is Alkermes’s revenue forecast?

Alkermes's average annual revenue forecast for its fiscal year ending in December 2026 is $1.46B, reflecting a -1.07% decrease from the reported $1.48B in 2025. The forecast for 2027 is $1.43B, and $1.47B for 2028.

What is Alkermes’s net income forecast?

Alkermes's net income forecast for the fiscal year ending in December 2026 stands at $211.64M, representing a -12.42% decrease from the reported $241.66M in 2025. Projections indicate $210.29M in 2027, and $304.67M in 2028.